Prospective Open‐Label Safety Study of Edaravone Dexborneol in Filipino Patients With Acute Ischemic Stroke

20260 citationsJournal Articlegold Open Access

Authors

Zenyros Faith Sabellano · José R. Reyes Memorial Medical Center

Bonifacio C Pedregosa · José R. Reyes Memorial Medical Center

Laurence Kristoffer Batino · University of Baguio

Jose C. Navarro · José R. Reyes Memorial Medical Center

Abstract

Edaravone dexborneol demonstrated a favorable safety profile in Filipino patients with acute ischemic stroke, with adverse events (AE) predominantly mild, transient, and reversible. These real-world findings align with international data and support their potential incorporation into acute stroke management pathways in the Philippines.

Topics & Keywords

Acute Ischemic Stroke Management Antiplatelet Therapy and Cardiovascular Diseases Neurological Disorders and Treatments

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Brain and Behavior

Volume 16, Issue 3, pp. e71272-e71272

DOI: 10.1002/brb3.71272

Field-Weighted Citation Impact: 0.00